ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 155 filers reported holding ANTARES PHARMA INC in Q1 2020. The put-call ratio across all filers is 347.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $12,487,000 | +206.3% | 3,045,999 | +166.6% | 0.02% | +214.3% |
| Q4 2021 | $4,077,000 | +220.8% | 1,142,491 | +226.8% | 0.01% | +250.0% |
| Q3 2021 | $1,271,000 | +211.5% | 349,593 | +101.9% | 0.00% | +100.0% |
| Q1 2020 | $408,000 | +101.0% | 173,156 | +300.1% | 0.00% | – |
| Q4 2019 | $203,000 | +40.0% | 43,281 | 0.0% | 0.00% | – |
| Q3 2019 | $145,000 | -89.0% | 43,281 | -90.0% | 0.00% | -100.0% |
| Q1 2019 | $1,316,000 | -51.0% | 434,594 | -56.0% | 0.00% | -66.7% |
| Q4 2018 | $2,686,000 | -28.0% | 988,812 | -11.0% | 0.01% | -14.3% |
| Q3 2018 | $3,732,000 | +27.4% | 1,110,597 | -2.2% | 0.01% | +16.7% |
| Q2 2018 | $2,930,000 | +49.6% | 1,135,517 | +27.5% | 0.01% | +100.0% |
| Q1 2018 | $1,959,000 | – | 890,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |